Clostridium Difficile News and Research

RSS
Clostridium difficile is a type of bacterium found in human and animal waste. Clostridium difficile is a common cause of diarrhea that occurs in hospitals. It can also cause diarrhea or other intestinal disorders in patients treated with antibiotics.
Frozen fecal transplantation effective at providing relief to C. diff patients

Frozen fecal transplantation effective at providing relief to C. diff patients

Researcher seeks to identify probiotic mixes to treat Clostridium difficile infections

Researcher seeks to identify probiotic mixes to treat Clostridium difficile infections

Discoveries could lead to development of novel therapies to prevent C. diff infection

Discoveries could lead to development of novel therapies to prevent C. diff infection

Common antibiotics can promote C. diff infections by killing off bile acid-altering microbes

Common antibiotics can promote C. diff infections by killing off bile acid-altering microbes

Candidiasis needs to be treated early, aggressively to help vulnerable hospitalized patients

Candidiasis needs to be treated early, aggressively to help vulnerable hospitalized patients

Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

Loyola professor receives prestigious 2015 Marion Spencer Fay Award

Loyola professor receives prestigious 2015 Marion Spencer Fay Award

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

UV robots help reduce rates of C. diff transmission among cancer inpatients

UV robots help reduce rates of C. diff transmission among cancer inpatients

Allergan's anti-infective portfolio to be highlighted at IDWeek 2015

Allergan's anti-infective portfolio to be highlighted at IDWeek 2015

New capsule form of FMT raises hopes for treating C. difficile infection

New capsule form of FMT raises hopes for treating C. difficile infection

Overall incidence of serious, highly drug-resistant group of bacteria relatively low in 2012-2013

Overall incidence of serious, highly drug-resistant group of bacteria relatively low in 2012-2013

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

Stanford researchers successfully defeat C. difficile bacteria

Stanford researchers successfully defeat C. difficile bacteria

New UC Davis study suggests that popular molecular tests over-diagnose C. difficile infections

New UC Davis study suggests that popular molecular tests over-diagnose C. difficile infections

Allergan announces positive results from AVYCAZ Phase III studies for treatment of cUTI

Allergan announces positive results from AVYCAZ Phase III studies for treatment of cUTI

FDA approves Allergan's sNDA to update label for TEFLARO (ceftaroline fosamil)

FDA approves Allergan's sNDA to update label for TEFLARO (ceftaroline fosamil)

Probiotics do not help prevent gastrointestinal colonization with MDROs in critically ill patients

Probiotics do not help prevent gastrointestinal colonization with MDROs in critically ill patients

Probiotics show no benefit in preventing gastrointestinal colonization with drug-resistant microbes in ICU patients

Probiotics show no benefit in preventing gastrointestinal colonization with drug-resistant microbes in ICU patients

No single genetic strain associated with the worst cases of C. difficile infections

No single genetic strain associated with the worst cases of C. difficile infections